Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States

Journal of the American Medical Directors Association

Volumn 11, Issue 9, 2010, Pages 617-628

  Grant, William B ^a   Peiris, Alan N ^b  

^a Sunlight   (United States)

^b East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

AFRICAN AMERICAN; BREAST CANCER; CARDIOVASCULAR DISEASE; COLORECTAL CANCER; EUROPEAN AMERICAN; HEALTH DISPARITY; HEALTH HAZARD; HUMAN; LIFESTYLE; MORTALITY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; REVIEW; SOCIAL ENVIRONMENT; SOCIAL STATUS; SYSTEMATIC REVIEW; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 77958452526     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.03.013     Document Type: Review

References (173)

1. National Center for Health Statistics. Health, United States, 2008 with Chartbook Hyattsville, MD: 2009. Available at: Accessed January 3, 2010. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/Health_US/hus08tables/table028.xls.
2. Morbidity and Mortality Weekly Report. Health disparities experienced by black or African Americans - United States. Centers for Disease Control, January 14, 2005 / 54(01);1-3. Available at: Accessed April 20, 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5401a1.htm.
3. Satcher D., Higginbotham E.J. The public health approach to eliminating disparities in health. Am J Public Health 2008, 98(9 Suppl):S8-S11.
4. Franks P., Fiscella K. Reducing disparities downstream: Prospects and challenges. J Gen Intern Med 2008, 23:672-677.
5. Orsi J.M., Margellos-Anast H., Whitman S. Black-White health disparities in the United States and Chicago: A 15-year progress analysis. Am J Public Health 2010, 100:349-356.
6. Hall W.D., Ferrario C.M., Moore M.A., et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci 1997, 313:195-209.
7. Voeks J.H., McClure L.A., Go R.C., et al. Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: The REasons for Geographic And Racial Differences in Stroke Study. Stroke 2008, 39:1675-1680.
8. Drewnowski A. Obesity, diets, and social inequalities. Nutr Rev 2009, 67(Suppl 1):S36-S39.
9. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009, 121:21-33.
10. Sudano J.J., Baker D.W. Explaining US racial/ethnic disparities in health declines and mortality in late middle age: The roles of socioeconomic status, health behaviors, and health insurance. Soc Sci Med 2006, 62:909-922.
11. Brondolo E., Gallo L.C., Myers H.F. Race, racism and health: Disparities, mechanisms, and interventions. J Behav Med 2009, 32:1-8.
12. Williams D.R., Mohammed S.A. Discrimination and racial disparities in health: Evidence and needed research. J Behav Med 2009, 32:20-47.
13. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
14. Taylor S.N., Wagner C.L., Fanning D., et al. Vitamin D status as related to race and feeding type in preterm infants. Breastfeed Med 2006, 1:156-163.
15. Tseng M., Giri V., Bruner D.W., Giovannucci E. Prevalence and correlates of vitamin D status in African American men. BMC Public Health 2009, 9:191.
16. Grant W.B. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 94:1867-1875.
17. Garland C.F., Garland F.C., Gorham E.D., et al. The role of vitamin D in cancer prevention. Am J Public Health 2006, 96:252-261.
18. Grant W.B. Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc 2006, 98:357-364.
19. Grant W.B., Garland C.F. The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006, 26:2687-2699.
20. Boscoe F.P., Schymura M.J. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2000. BMC Cancer 2006, 6:264.
21. Grant W.B. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking. Int J Cancer 2007, 120:1123-1127.
22. Parker J., Hashmi O., Dutton D., et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 2010, 65:225-236.
23. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179:2060-2063.
24. Grant W.B., Giovannucci D. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol 2009, 1:215-219.
25. Cannell J.J., Zasloff M., Garland C.F., et al. On the epidemiology of influenza. Virol J 2008, 5:29.
26. Llewellyn D.J., Langa K.M., Lang I.A. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009, 22:188-195.
27. Looker A.C., Pfeiffer C.M., Lacher D.A., et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527.
28. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
29. Moreno-Reyes R., Carpentier Y.A., Boelaert M., et al. Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults. Eur J Nutr 2009, 48:31-37.
30. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr 2004, 80(6 Suppl):1763S-1766S.
31. Moore C.E., Murphy M.M., Holick M.F. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr 2005, 135:2478-2485.
32. Gorham E.D., Garland C.F., Garland F.C., et al. Optimal vitamin D status for colorectal cancer prevention a quantitative meta analysis. Am J Prev Med 2007, 32:210-216.
33. Lappe J.M., Travers-Gustafson D., Davies K.M., et al. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.
34. Cannell J.J., Hollis B.W. Use of vitamin D in clinical practice. Altern Med Rev 2008, 13:6-20.
35. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842-856.
36. Teixeira D.S., Castro L.C., Nóbrega Y.K., et al. 25-Hydroxy-vitamin D levels among Callithrix penicillata primate species raised in captivity. J Med Primatol 2009 Dec 15, [Epub ahead of print].
37. Age-Adjusted Septicemia Death Rates by Race and Sex Michigan and United States Residents, 1999-2007. Available at: Accessed January 18, 2010. http://www.mdch.state.mi.us/pha/osr/deaths/SepticemiaDX.asp.
38. Grant W.B., Holick M.F. Benefits and requirements of vitamin D for optimal health: A review. Altern Med Rev 2005, 10:94-111.
39. Hyppönen E., Power C. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007, 85:860-868.
40. Grant W.B., Garland C.F. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004, 48:115-123.
41. Frost P. Black-white differences in cancer risk and the vitamin D hypothesis. J Natl Med Assoc 2009, 101:1310-1312.
42. Garland C.F., Gorham E.D., Mohr S.B., et al. Vitamin D and prevention of breast cancer: Pooled analysis. J Steroid Biochem Mol Biol 2007, 103:708-711.
43. Abbas S., Linseisen J., Slanger T., et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer-results of a large case-control study. Carcinogenesis 2008, 29:93-99.
44. Freedman D.M., Chang S.C., Falk R.T., et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008, 17:889-894.
45. Abbas S., Chang-Claude J., Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2009, 124:250-255.
46. Crew K.D., Gammon M.D., Steck S.E., et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa) 2009, 2:598-604.
47. Almquist M, Bondeson AG, Bondeson L, et al. Serum levels of vitamin D, PTH, calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer. 2010 Jan 28. [Epub ahead of print].
48. Wu K., Feskanich D., Fuchs C.S., et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007, 99:1120-1129.
49. Otani T., Iwasaki M., Sasazuki S., et al. Plasma vitamin D and risk of colorectal cancer: The Japan Public Health Center-Based Prospective Study. Br J Cancer 2007, 97:446-451.
50. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: A nested case-control study. BMJ 2010, 340:b5500.
51. Woolcott C.G., Wilkens L.R., Nomura A.M., et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2010, 19:130-134.
52. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008, 168:1174-1180.
53. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
54. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
55. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J Am Geriatr Soc 2009, 57:1595-1603.
56. Kilkkinen A., Knekt P., Aro A., et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009, 170:1032-1039.
57. Semba R.D., Houston D.K., Bandinelli S., et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010, 64:203-209.
58. Grant WB, Schwalfenberg GK, Genuis SJ, Whiting SJ. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Molec Nutr Food Res. 2010 Mar 29. [Epub ahead of print].
59. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
60. Reis J.P., von Mühlen D., Michos E.D., et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 2009, 207:585-590.
61. Zittermann A., Schleithoff S.S., Götting C., et al. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008, 10:321-327.
62. Pilz S., Dobnig H., Fischer J.E., et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39:2611-2613.
63. Yin L., Grandi N., Raum E., et al. Meta-analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009, 30:113-125.
64. Tretli S., Hernes E., Berg J.P., et al. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009, 100:450-454.
65. Yin L., Raum E., Haug U., et al. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. Cancer Epidemiol 2009, 33:435-445.
66. Zhou W., Heist R.S., Liu G., et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007, 25:479-485.
67. Kilkkinen A., Knekt P., Heliövaara M., et al. Vitamin D status and the risk of lung cancer: A cohort study in Finland. Cancer Epidemiol Biomarkers Prev 2008, 17:3274-3278.
68. Mohr S.B., Garland C.F., Gorham E.D., et al. Could ultraviolet B irradiance and vitamin D be associated with lower incidence rates of lung cancer?. J Epidemiol Community Health 2008, 62:69-74.
69. Black P.N., Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 2005, 128:3792-3798.
70. Urashima M., Segawa T., Okazaki M., et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010 Mar 10, [Epub].
71. Grant W.B. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinol 2009, 1:37-42.
72. Jeng L., Yamshchikov A.V., Judd S.E., et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009, 7:28.
73. Kim D.H., Sabour S., Sagar U.N., et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
74. Ix J.H., Allison M.A., Denenberg J.O., et al. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol 2008, 51:2347-2354.
75. Grant W.B. Lower vitamin D status may explain the higher prevalence of peripheral arterial disease among African Americans. J Am Coll Cardiol 2008, 52:1432. author reply 1432-1433.
76. Reis J.P., Michos E.D., von Mühlen D., Miller E.R. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008, 88:1469-1477.
77. Bahrami H., Kronmal R., Bluemke D.A., et al. Differences in the incidence of congestive heart failure by ethnicity: The multi-ethnic study of atherosclerosis. Arch Intern Med 2008, 168:2138-2145.
78. Grant W.B. Differences in vitamin D levels likely explain ethnic differences in incidence of congestive heart failure. Arch Intern Med 2009, 169:1075.
79. Ashraf A., Alvarez J., Saenz K., et al. Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab 2009, 94:3200-3206.
80. Wilkins C.H., Birge S.J., Sheline Y.I., Morris J.C. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009, 101:349-354.
81. Gutiérrez O.M., Isakova T., Andress D.L., et al. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 2008, 73:956-962.
82. Melamed M.L., Astor B., Michos E.D., et al. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009, 20:2631-2639.
83. Scragg R., Sowers M., Bell C. Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2813-2818.
84. Giovannucci E., Liu Y., Willett W.C. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev 2006, 15:2467-2472.
85. Baquet C.R., Mishra S.I., Commiskey P., et al. Breast cancer epidemiology in blacks and whites: Disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2008, 100:480-488.
86. Grant W.B. Differences in vitamin D status may explain black-white differences in breast cancer survival rates. J Natl Med Assoc 2008, 100:1040.
87. Neuhouser M.L., Sorensen B., Hollis B.W., et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008, 88:133-139.
88. Alexander D.D., Waterbor J., Hughes T., et al. African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: An epidemiologic review. Cancer Biomark 2007, 3:301-313.
89. Albain K.S., Unger J.M., Crowley J.J., et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009, 101:984-992.
90. Aloia J.F., Li-Ng M. Re: Epidemic influenza and vitamin D. Epidemiol Infect 2007, 135:1095-1096. author reply 1097-1098.
91. Esper A.M., Moss M., Lewis C.A., et al. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 2006, 34:2576-2582.
92. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L. Occurrence and outcomes of sepsis: Influence of race. Crit Care Med 2007, 35:763-768.
93. Fiscella K., Franks P. Vitamin D, race, and cardiovascular mortality: Findings from a national US sample. Ann Fam Med 2010, 8:11-18.
94. Block G., Cox C., Madans J., et al. Vitamin supplement use, by demographic characteristics. Am J Epidemiol 1988, 127:297-309.
95. Freedman B.I., Wagenknecht L.E., Hairston K.G., et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010, 95:1076-1083.
96. Peiris A.N., Sothmann M.S., Hoffmann R.G., et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989, 110:867-872.
97. Max W., Sung H.Y., Tucker L.Y., Stark B. The disproportionate cost of smoking for African Americans in California. Am J Public Health 2010, 100:152-158.
98. Mackay-Sim A., Féron F., Eyles D., et al. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol 2004, 59:351-380.
99. Eyles D.W., Feron F., Cui X., et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 2009, 34(Suppl 1):S247-S257.
100. de Abreu D.A., Nivet E., Baril N., et al. Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav Brain Res 2010, 208:603-608.
101. Dealberto M.J. Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both?. Med Hypotheses 2007, 68:259-267.
102. Humble M.B., Gustafsson S., Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: Relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol 2010 Mar 6, [Epub ahead of print].
103. Waite R., Killian P. Perspectives about depression: Explanatory models among African-American women. Arch Psychiatr Nurs 2009, 23:323-333.
104. Luke S., Salihu H.M., Alio A.P., et al. Risk factors for major antenatal depression among low-income African American women. J Womens Health (Larchmt) 2009, 18(11):1841-1846.
105. Joo J.H., Morales K.H., de Vries H.F., Gallo J.J. Disparity in use of psychotherapy offered in primary care between older African-American and white adults: Results from a practice-based depression intervention trial. J Am Geriatr Soc 2010, 58(1):154-160.
106. Wilkins C.H., Sheline Y.I., Roe C.M., et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006, 14:1032-1040.
107. Buell J.S., Scott T.M., Dawson-Hughes B., et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009, 64:888-895.
108. Przybelski R.J., Binkley N.C. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007, 460:202-205.
109. Wilkins C.H., Birge S.J., Sheline Y.I., Morris J.C. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009, 101:349-354.
110. McCann J.C., Ames B.N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J 2008, 22:982-1001.
111. Norman A.W. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88:491S-499S.
112. Buell J.S., Scott T.M., Dawson-Hughes B., et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009, 64:888-895.
113. Shipowick C.D., Moore C.B., Corbett C., Bindler R. Vitamin D and depressive symptoms in women during the winter: A pilot study. Appl Nurs Res 2009, 22:221-225.
114. Grant W.B. Does vitamin D reduce the risk of dementia?. J Alzheimers Dis 2009, 17:151-159.
115. Buell J.S., Dawson-Hughes B., Scott T.M., et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74:18-26.
116. Cekic M., Stein D.G. Traumatic brain injury and aging: Is a combination of progesterone and vitamin D hormone a simple solution to a complex problem?. Neurotherapeutics 2010, 7:81-90.
117. Arteh J., Narra S., Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2009 Dec 4, [Epub ahead of print].
118. Cutler L. Could vitamin D be the missing ingredient in HCV therapy? 2009. Available at: Accessed January 18, 2010. http://www.hepatitis-central.com/mt/archives/2009/12/could_vitamin_d.html.
119. Ginde A.A., Mansbach J.M., Camargo C.A. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep 2009, 9:81-87.
120. de la Torre M.S., Torres C., Nieto G., et al. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J Infect Dis 2008, 197:405-410.
121. Rovner A.J., Stallings V.A., Kawchak D.A., et al. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 2008, 108:1512-1516.
122. Kyriakidou-Himonas M., Aloia J.F., Yeh J.K. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab 1999, 84:3988-3990.
123. Bhuriya R., Li S., Chen S.C., et al. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: An analysis from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2009, 53(4 Suppl. 4):S3-S10.
124. Talwar S.A., Swedler J., Yeh J., et al. Vitamin-D nutrition and bone mass in adolescent black girls. J Natl Med Assoc 2007, 99:650-657.
125. Akhter N., Sinnott B., Mahmood K., et al. Effects of vitamin D insufficiency on bone mineral density in African American men. Osteoporos Int 2009, 20:745-750.
126. Ryan L.M., Brandoli C., Freishtat R.J., et al. Prevalence of vitamin D insufficiency in African American children with forearm fractures: A preliminary study. J Pediatr Orthop 2010, 30:106-109.
127. Tripathi S.S., Gibney E.M., Gehr T.W., et al. High prevalence of vitamin D deficiency in African American kidney transplant recipients. Transplantation 2008, 85:767-770.
128. Datta S., Alfaham M., Davies D.P., et al. Vitamin D deficiency in pregnant women from a non-European ethnic minority population-an interventional study. BJOG 2002, 109(8):905-908.
129. Bodnar L.M., Simhan H.N., Powers R.W., et al. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007, 137:447-452.
130. Merewood A., Mehta S.D., Chen T.C., et al. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab 2009, 94:940-945.
131. Bodnar L.M., Krohn M.A., Simhan H.N. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 2009, 139:1157-1161.
132. Bodnar L.M., Catov J.M., Simhan H.N., et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007, 92:3517-3522.
133. Hollis B.W. Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 2007, 22(Suppl 2):V39-V44.
134. Hollis BW, Wagner CL. Randomized controlled trials to determine the safety of vitamin D supplementation during pregnancy and lactation. Paper presented at: 14th Workshop on Vitamin D; Brugge, Belgium; October 14-18, 2009. Abstracts, p. 134.
135. Skinner H.G., Schwartz G.G. A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:575-578.
136. Devesa S.S., Grauman D.J., Blot W.J., et al. Atlas of Cancer Mortality in the United States, 1950-1994 1999, National Institutes of Health, Rockville, MD, NIH Publication No. 99-4564.
137. Grant W.B. A multicountry ecological study of risk-modifying factors for prostate cancer: Apolipoprotein E ε4 as a risk factor and cereals as a risk reduction factor. Anticancer Res 2010, 30:189-199.
138. Volcik K.A., Barkley R.A., Hutchinson R.G., et al. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am J Epidemiol 2006, 164:342-348.
139. Martins I.J., Hone E., Foster J.K., et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 2006, 11:721-736.
140. Roses A.D. On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. J Alzheimers Dis 2006, 9(3 Suppl):361-366.
141. Grant W.B. Dietary links to Alzheimer's disease. Alz Dis Rev 1997, 2:42-55. Available at, http://www.sunarc.org/JAD97.pdf. Accessed January 20, 2010.
142. Hendrie H.C., Osuntokun B.O., Hall K.S., et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995, 152:1485-1492.
143. Jablonski N.G., Chaplin G. The evolution of human skin coloration. J Hum Evol 2000, 39:57-106.
144. Pittas A.G., Dawson-Hughes B., Li T., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29:650-656.
145. Peterlik M., Grant W.B., Cross H.S. Calcium, vitamin D and cancer. Anticancer Res 2009, 29:3687-3698.
146. Aloia J.F. African Americans, 25-hydroxyvitamin D, and osteoporosis: A paradox. Am J Clin Nutr 2008, 88(Supp):545S-550S.
147. Benjamin A., Moriakova A., Akhter N., et al. Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int 2009, 20:1795-1803.
148. Winters S.J., Chennubhatla R., Wang C., Miller J.J. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 2009, 58:438-442.
149. Nasir K., Shaw L.J., Liu S.T., et al. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol 2007, 50:953-960.
150. Taylor A.J., Wu H., Bindeman J., et al. Comparison of coronary artery calcium progression in African American and white men. J Cardiovasc Comput Tomogr 2009, 3:71-77.
151. Grant W.B. In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance. Dermatoendocrinology 2009, 1:207-214.
152. Hamada K., Nagai S., Tsutsumi T., Izumi T. Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis. Eur Respir J 1998, 11:1015-1020.
153. Hewison M., Kantorovich V., Liker H.R., et al. Vitamin D-mediated hypercalcemia in lymphoma: Evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 2003, 18:579-582.
154. Webb A.R., Kline L., Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988, 67:373-378.
155. Webb A.R., Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 2006, 82:1697-1703.
156. Holick M.F. Sunlight, UV-radiation, vitamin D and skin cancer: How much sunlight do we need?. Adv Exp Med Biol 2008, 624:1-15.
157. Houghton L.A., Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006, 84:694-697.
158. Heaney R.P., Davies K.M., Chen T.C., et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
159. Aloia J.F., Patel M., Dimaano R., et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008, 87:1952-1958.
160. Lagunova Z., Porojnicu A.C., Lindberg F., et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009, 29:3713-3720.
161. Brot C., Jorgensen N.R., Sorensen O.H. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999, 53:920-926.
162. Skinner H.G., Michaud D.S., Giovannucci E., et al. Vitamin D intake and the risk of pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006, 15:1688-1695.
163. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169:551-561.
164. Kristal A.R. Are clinical trials the " gold standard" for cancer prevention research?. Cancer Epidemiol Biomarkers Prev 2008, 17:3289-3291.
165. Hill A.B. The environment and disease: Association or causation?. Proc R Soc Med 1965, 58:295-300.
166. Grant W.B. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermatoendocrinology 2009, 1:17-24.
167. Grant WB. Role of vitamin D in cancer risk reduction and treatment. J Soc Integr Oncol. In press.
168. Harris S.S. Vitamin D and African Americans. J Nutr 2006, 136:1126-1129.
169. Grant W.B., Cross H.S., Garland C.F., et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol 2009, 99:104-113.
170. Hurley K.M., Oberlander S.E., Merry B.C., et al. The healthy eating index and youth healthy eating index are unique, nonredundant measures of diet quality among low-income, African American adolescents. J Nutr 2009, 139:359-364.
171. Peiris A.N., Bailey B.A., Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Mil Med 2008, 173:1214-1218.
172. Rajakumar K., Fernstrom J.D., Holick M.F., et al. Vitamin D status and response to Vitamin D(3) in obese vs non-obese African American children. Obesity (Silver Spring) 2008, 16:90-95.
173. Bibuld D. Health disparities and vitamin D. Clinic Rev Bone Miner Metab 2009, 7:63-76.